Clinical Researchers at University of Rhode Island Adopt AB SCIEX Technology to Develop Novel Test to Support Organ Transplants

FOSTER CITY, Calif.--(BUSINESS WIRE)--AB SCIEX, a global leader in life science analytical technologies, today announced that the Clinical Pharmacokinetics Research Laboratory at the University of Rhode Island’s College of Pharmacy is using AB SCIEX mass spectrometry technology to develop a novel test that would enable clinical researchers to use saliva to monitor immunosuppressant drugs commonly administered to make organ transplants successful.

MORE ON THIS TOPIC